Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 42, 2018 - Issue 5-6
Submit an article Journal homepage
427
Views
19
CrossRef citations to date
0
Altmetric
Short Communication

Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition

Efthymia VlachakiAdult Thalassaemia Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece;
,
Eleni GavriilakiHaematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece; Correspondence[email protected]
,
Katerina KafantariAdult Thalassaemia Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece;
,
Despoina AdamidouBlood Bank, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece;
,
Dimitris TsitsikasHaemoglobinopathy Service, Homerton University Hospital National Health Service Foundation Trust, London, UK;
,
Eleni ChasapopoulouBlood Bank, AHEPA Hospital, Thessaloniki, Greece
,
Achilles AnagnostopoulosHaematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
&
Apostolos TsapasAdult Thalassaemia Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece;
show all
Pages 339-341 | Received 22 Sep 2018, Accepted 20 Oct 2018, Published online: 09 Jan 2019

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christos Varelas, Athina Tampaki, Ioanna Sakellari, Αchilles Anagnostopoulos, Eleni Gavriilaki & Efthymia Vlachaki. (2021) Complement in Sickle Cell Disease: Are We Ready for Prime Time?. Journal of Blood Medicine 12, pages 177-187.
Read now
Sawsan A Omer, Jafar S Alaesh & Kefah B Algadeeb. (2020) Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Case Report. International Medical Case Reports Journal 13, pages 307-311.
Read now

Articles from other publishers (17)

France Pirenne & Corinne Pondarré. (2023) Alloimmunization and hyperhemolysis in sickle cell disease. Hematology 2023:1, pages 653-659.
Crossref
Christos Varelas & Eleni Gavriilaki. (2023) Sickle Cell Disease: Current Understanding and Future Options. Journal of Clinical Medicine 12:18, pages 5943.
Crossref
Anna Duval & Véronique Frémeaux‐Bacchi. (2023) Complement biology for hematologists. American Journal of Hematology 98:S4.
Crossref
Mark T. Friedman, Kamille A. West, Peyman Bizargity, Kyle Annen, H. Deniz Gur & Timothy HilbertMark T. Friedman, Kamille A. West, Peyman Bizargity, Kyle Annen, H. Deniz Gur & Timothy Hilbert. 2023. Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy. Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy 323 329 .
John D. Belcher, Julia Nguyen, Chunsheng Chen, Fuad Abdulla, Ruan Conglin, Zalaya K. Ivy, Jason Cummings, Thomas Dudler & Gregory M. Vercellotti. (2022) MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. Translational Research 249, pages 1-12.
Crossref
Eleni Gavriilaki, Régis Peffault de Latour & Antonio Maria Risitano. (2022) Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond. Blood 139:25, pages 3571-3582.
Crossref
Christos Varelas, Eleni Gavriilaki, Ioanna Sakellari, Philippos Klonizakis, Evaggelia-Evdoxia Koravou, Ioanna Christodoulou, Ioulia Mavrikou, Andreas Kourelis, Fani Chatzopoulou, Dimitrios Chatzidimitriou, Tasoula Touloumenidou, Apostolia Papalexandri, Achilles Anagnostopoulos & Efthimia Vlachaki. (2022) Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center. Journal of Clinical Medicine 11:4, pages 937.
Crossref
Rim Abdallah, Herleen Rai & Sandhya R. Panch. (2021) Transfusion Reactions and Adverse Events. Clinics in Laboratory Medicine 41:4, pages 669-696.
Crossref
Richard C. Zanetti, Lauren M. Vasta, Kristen Romanelli & Thomas C. Newton. (2021) Management of Hyperhemolysis in β-thalassemia With Multiple Immunosuppressives, Including Complement Blockade. Journal of Pediatric Hematology/Oncology 43:8, pages e1145-e1147.
Crossref
Athina Tampaki, Eleni Gavriilaki, Christos Varelas, Achilles Anagnostopoulos & Efthymia Vlachaki. (2021) Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing. Blood Reviews 48, pages 100805.
Crossref
Grace E. Linder & Stella T. Chou. (2021) Red cell transfusion and alloimmunization in sickle cell disease. Haematologica 106:7, pages 1805-1815.
Crossref
Yuanjun Wu, Yanli Ji, Bingmei Dai, Faliang Guo, Yong Wu, Ziyi He, Chunyan Mo, Shujie Wu & Yingming Hu. (2020) A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion. Transfusion Medicine 31:1, pages 24-29.
Crossref
Melissa Azul, Surbhi Shah, Sarah Williams, Gregory M. Vercellotti & Alexander A. Boucher. (2021) Evidence for complement-mediated bone marrow necrosis in a young adult with sickle cell disease. Blood Cells, Molecules, and Diseases 86, pages 102508.
Crossref
Lakshman Vasanthamohan, Sheryl Choo, Tonisha Marshall, Yahui Tammy Symons, Doreen Matsui, Genevieve Eastabrook & Ziad Solh. (2020) Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review. Transfusion 60:10, pages 2448-2455.
Crossref
Aline Floch, Alexandre Morel, Fabian Zanchetta-Balint, Catherine Cordonnier-Jourdin, Slimane Allali, Maximilien Grall, Ghislaine Ithier, Benjamin Carpentier, Sadaf Pakdaman, Jean-Claude Merle, Radjiv Goulabchand, Tackwa Khalifeh, Ana Berceanu, Cécile Helmer, Christelle Chantalat-Auger, Véronique Frémeaux-Bacchi, Marc Michel, Mariane de Montalembert, Armand Mekontso-Dessap, France Pirenne, Anoosha Habibi & Pablo Bartolucci. (2020) Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease. Haematologica 105:11, pages 2694-2697.
Crossref
France Pirenne. (2019) The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell disease. Current Opinion in Hematology 26:6, pages 488-494.
Crossref
Christopher J Patriquin & Kevin H.M. Kuo. (2019) Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics. Transfusion Medicine Reviews 33:4, pages 256-265.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.